Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 6 , Pages 405-411 , July 2010

Cardiovascular disease in Latin American women

  • M.E. Tejero

      Affiliations

    • Instituto Nacional de Medicina Genómica, Periférico Sur 4124, Colonia Ex Rancho de Anzaldo, CP 01900 Mexico City, Mexico
    • Departamento de Salud, Universidad Iberoamericana, Campus Santa Fe, Prol Reforma 880, Colonia Lomas de Santa Fe, CP 01219, Mexico City, Mexico
    • Corresponding Author InformationInstituto Nacional de Medicina Genómica, Periférico Sur 4124, Colonia Ex Rancho de Anzaldo, CP 01900 Mexico City, Mexico. Tel.: +52 5553501900× 1145.

Received 1 June 2009 ,Revised 14 January 2010 ,Accepted 2 February 2010.

References 

  1. World Health Organization . Cardiovascular disease. February 2007;www.WHO.orgFact sheet No 317
  2. Albala C, Vio F, Yanez M. Epidemiological transition in Latin America: a comparison of four countries. Rev Med Chil. 1997;125:719
  3. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part 1: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746
  4. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases. JAMA. 2004;291:2616
  5. Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, Vecchia CL. Mortality from cardiovascular and cerebrovascular disease in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil. 2009;[Epub ahead of publication]
  6. Tanowitz HB, Machado FS, Jelicks LA, Shirani J, de Carvalho AC, Spray DC, et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis. 2009;51:524
  7. Bocchi EA, Guimaraes G, Tarasouthshi F, Spina G, Mangini S, Bacal F. Cardiomyopathy, adult valve disease and heart failure in South America. Heart. 2009;95:181
  8. Barceló A. Cardiovascular diseases in Latin America and the Caribbean. Lancet. 2006;368:625
  9. Schardgrodsky H, Escobar MC, Escobar E. Cardiovascular disease prevention: a challenge for Latin America. Circulation. 1998;98:2103
  10. www.WHO.org
  11. Rodríguez T, Malvezzi M, Chatenoud L, Bosetti C, Levi F, Negri E, et al. Trends in mortality from coronary heart and cerebrovascular disease in the Americas: 1970-2000. Heart. 2006;92:453
  12. Health in the Americas 2009. www.paho.org
  13. Pramparo P. The epidemiology of hypertension in South America. J Hum Hypertens. 2002;1(16 Suppl.):S3
  14. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, et al. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab. 2009 Dec;[Epub ahead of print]
  15. Aguilar-Salinas CA, García EG, Robles L, Riaño D, Ruiz-Gomez DG, García-Ulloa AC, et al. Cardiovascular risk evaluated by C-reactive protein levels in diabetic and obese Mexican subjects. Circ J. 2008;72:1170
  16. Hassel T. Rural poverty. Health and life style presented at: R14th Inter American meeting at the ministerial level, on health and agriculture. Mexico City; 2005.
  17. No authors listed . Gender in view. GIRE. 1998;Mar: 6
  18. López-Jaramillo P, Pradilla LP, Castillo VR, Lahera V. Patología socieconómica como causa de las diferencias regionales en las prevalencias de síndrome metabólico e hipertensión inducida por el embarazo. Rev Esp Cardiol. 2007;60:168–178
  19. Loewy M. Aging in the Americas. Perspect Health - Magazine Pan Am Health Organ. 2004;9(1):
  20. Melendez J, Guevara A, Arcia N, Leon Diaz E, Mrin C, Alfonso JC. Chronic diseases and functional limitation in older adults: a comparative study in seven cities of Latin America and the Caribbean rev panam salud publica 2005;17:353.
  21. Barria RM, Amigo H. Nutrition transition: a review of Latin American profile. Arch Latinoam Nutr. 2006;56:3
  22. Romieu I, Hernández-Avila M, Rivera JA, Ruel MT, Parra S. Dietary studies in countries experiencing a health transition: Mexico and Central America. Am J Clin Nutr. 1997;65S:1159S–1165S
  23. Cuevas A, Alvarez J, Olivos C. The emerging obesity problem in Latin America. Expert Rev Cardiovasc Ther. 2009;7:281–288
  24. Smith SC. Risk factors for myocardial infarction in Latin American. Sobrepeso y Obesidad. Circulation. 2007;115:1061
  25. Encuesta Nacional de Salud y Nutrición . www.insp.mx/ensanut2006;
  26. Rivera JA, Barquera S, Campirano F, Campos I, Safdie M, Tovar V. Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr 5(1A):113.
  27. Lanas F, Avezm A, Bautista L, Diaz R, Luna M, Islam S, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115:1067
  28. Kabagambe EK, Baylin A, Campos H. Nonfatal acute myocardial infarction in Costa Rica: modifiable risk factors, population-attributable risks, and adherence to dietary guidelines. Circulation. 2007;115:1075
  29. http://www.who/topics/diabetes
  30. Villa Nueva. First epidemiologic study of diabetes mellitus and hypertension in Guatemala. http://www.paho.org
  31. Comuzzie AG, Tejero ME, Funahashi T, Martin LJ, Kissebah A, Takahashi M, et al. The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes. Hum Biol. 2007;79:191
  32. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, Silva H, Vinueza R, Silva Aycaguer LC, et al. Wilson CARMELA study investigators. Am J Med. 2008;121:58
  33. Whelton PK, He J, Appel LJ. Treatment and prevention of hypertension. In:  Manson JE,  Ridker PM,  Gaziano JM,  Hennekens CH editor. Prevention of myocardial infarction. New York, NY: Oxford University Press; 1996;p. 154
  34. Orduñez P, Silva LC, Rodriguez MP. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance?. Rev Panam Salud Publica. 2001;10:226
  35. Arredondo A, Zuniga A, Parada I. Health costs and financial consequences of epidemiological changes in chronic diseases in Latin America: Evidence from Mexico. Public Health. 2005;119:711
  36. Kuri-Morales P, Emberson J, Alegre-Diza J, Tapia Conyer R, Collins R, Peto R, et al. The prevalence of chronic diseases and major disease risk factors at different ages among 150 000 men and women living in Mexico City: cross-sectional analyses of a prospective study. BMC Public Health. 2009;9:9
  37. Hays JT, Hurt RD, Dale LC. In:  Anson JE,  Ridker P,  Gaziano J,  Hennekens CH editor. Prevention of myocardial infarction Smoking cessation. 99:New York, NY: Oxford University Press; 1996;
  38. da Costa e Silva VL, Koifman S. Smoking in Latin America: a major public health problem. Cad Saude Publica. 1998;14(suppl 3):99
  39. Muller F, Wehbe L. Smoking and smoking cessation in Latin America: a review of the current situation and available treatments. Int J Chron Obstruct Pulmon Dis. 2008;3:285–293
  40. Ciruzzi M, Pramparo P, Esteban O, Rozlosnik J, Tartaglione J, Abecasis B, et al. Case-control study of passive smoking at home and risk of acute myocardial infarction. Argentine FRICAS investigators. Factores de Riesgo Coronario en América del Sur. J Am Coll Cardiol. 1998;15:797–803
  41. Ciruzzi M, Schargrodsky H, Rozlosnik J, Pramparo P, Delmonte H, Rudich V, et al. Frequency of family history of acute myocardial infarction in patients with acute myocardial infarction. Argentine FRICAS (Factores de Riesgo Coronario en America del Sur) Investigators. Am J Cardiol. 1997;80:122–127
  42. Chiodini BD, Lewis CV. Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Atheroscler Thromb Basc Biol. 2003;23:1863
  43. Auro K, Alanne M, Kristiansson K, Silander K, Kuulasama K, Salomaa V, et al. Combined effects of thrombosis pathway gene variants predict Cardiovascular events. PLOS Genet. 2007;3:e120
  44. Silva-Zolezzi I, Hidalgo-Miranda A, Estrada-Gil J, Fernandez-Lopez JC, Uribe-Figueroa L, Contreras A, et al. Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico. Proc Natl Acad Sci U S A. 2009;[Epub ahead of print]
  45. Sans M. Admixture studies in Latin America: from the 20th to the 21st century. Hum Biol. 2000;72:155
  46. Forouhi NG, Sattar N. Cardiovascular risk factors and ethnicity. A homogeneous relationship?. Atheroscler Suppl. 2006;7:11
  47. Bastarrachea RA, Kent JW, Rozada G, Cole SA, López-Alvarenga JC, Aradillas C, et al. Heritability and genetic correlations of metabolic disease-related phenotypes in mexico: preliminary report from the gemm family study. Hum Biol. 2007;79:121
  48. Ounpuu S, Negassa A, Yusuf S. INTER-HEART: a global study of risk factors for acute myocardial infarction. Am Heart J. 2001;141:711
  49. Curioni C, Cunha CB, Veras RP, Andre C. The decline in mortality from circulatory diseases in Brazil. Rev Panam Salud Publica. 2009;25:9
  50. Coitinho D, Monteiro C, Popkin B. What is Brazil doing to promote healthy diets and active lifestyles?. Public Health Nutr. 2002;5:263
  51. Arredondo A, Zuñiga A, Parada I. Health costs and financial consequences of epidemiological changes in chronic disease in Latin America. Evidence from Mexico. Public Health. 2005;119:711
  52. Encuesta nacional de enfermedades crónicas. 3rd ed.. Secretaria de salud de Mexico; 1996;

PII: S0939-4753(10)00040-2

doi: 10.1016/j.numecd.2010.02.005

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 6 , Pages 405-411 , July 2010

Article Tools

* Image Usage & Resolution